Caribou Biosciences, Inc. (CRBU) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 2.4M | 3.94M | 2.2M | 2.67M | 2.35M | 2.08M | 2.02M | 3.46M | 2.43M | 3.56M | 23.66M | 3.75M |
| Revenue Growth % | 1.87% | 89.74% | 8.6% | -23.01% | -3.13% | -41.62% | -91.45% | -7.75% | -30.64% | -3.63% | 616.38% | -10.42% |
| Cost of Goods Sold | 649K | 0 | 0 | 0 | 0 | 29.86M | 0 | 856K | 710K | 1.97M | 28.58M | 26.5M |
| COGS % of Revenue | 27.08% | - | - | - | - | 1437.84% | - | 24.71% | 29.23% | 55.48% | 120.8% | 705.81% |
| Gross Profit | 1.75M | 3.94M | 2.2M | 2.67M | 2.35M | -27.79M | 2.02M | 2.61M | 1.72M | 1.58M | -4.92M | -22.75M |
| Gross Margin % | 72.92% | 100% | 100% | 100% | 100% | -1337.84% | 100% | 75.29% | 70.77% | 44.52% | -20.8% | -605.81% |
| Gross Profit Growth % | -25.71% | 114.18% | 8.6% | 2.26% | 36.88% | -1854.23% | 141.12% | 111.46% | 107.74% | 107.19% | -249.02% | -23.72% |
| Operating Expenses | 28.03M | 32.39M | 31.6M | 50.24M | 45.27M | 11.09M | 40.26M | 46.11M | 47.72M | 39.03M | 9.71M | 10.12M |
| OpEx % of Revenue | 1169.3% | 821.97% | 1437.58% | 1883.95% | 1923.76% | 533.85% | 1989.23% | 1331.09% | 1964.64% | 1096.85% | 41.04% | 269.51% |
| Selling, General & Admin | 8.07M | 8.58M | 9.2M | 10.4M | 9.73M | 10.49M | 9.84M | 10.63M | 14.64M | 7.75M | 9.71M | 10.12M |
| SG&A % of Revenue | 336.5% | 217.69% | 418.43% | 390.06% | 413.73% | 504.96% | 486.22% | 306.84% | 602.84% | 217.73% | 41.04% | 269.51% |
| Research & Development | 20.61M | 23.82M | 22.4M | 27.69M | 35.53M | 30.46M | 30.42M | 35.48M | 33.79M | 31.28M | 28.58M | 26.5M |
| R&D % of Revenue | 859.87% | 604.29% | 1019.15% | 1038.32% | 1510.03% | 1466.73% | 1503.01% | 1024.25% | 1391.03% | 879.12% | 120.8% | 705.81% |
| Other Operating Expenses | -649K | 0 | 0 | 1000K | 0 | -1000K | 0 | 0 | -710K | 0 | -1000K | -1000K |
| Operating Income | -26.28M | -28.45M | -29.4M | -47.58M | -42.91M | -38.88M | -38.24M | -43.5M | -46M | -37.44M | -14.63M | -32.87M |
| Operating Margin % | -1096.37% | -721.97% | -1337.58% | -1783.95% | -1823.76% | -1871.69% | -1889.23% | -1255.8% | -1893.87% | -1052.33% | -61.84% | -875.31% |
| Operating Income Growth % | 38.76% | 26.81% | 23.11% | -9.37% | 6.71% | -3.83% | -161.31% | -32.35% | -47.84% | -22.45% | 44.86% | -15.61% |
| EBITDA | -25.63M | -27.77M | -28.77M | -46.41M | -41.75M | -37.69M | -37.06M | -42.65M | -45.29M | -36.7M | -13.05M | -32.25M |
| EBITDA Margin % | -1069.3% | -704.67% | -1308.87% | -1740.19% | -1774.25% | -1814.68% | -1831.08% | -1231.09% | -1864.64% | -1031.53% | -55.17% | -858.88% |
| EBITDA Growth % | 38.61% | 26.32% | 22.37% | -8.83% | 7.82% | -2.69% | -183.91% | -32.23% | -48.37% | -22.05% | 49.96% | -14.88% |
| D&A (Non-Cash Add-back) | 649K | 682K | 631K | 1.17M | 1.17M | 1.18M | 1.18M | 856K | 710K | 740K | 1.58M | 617K |
| EBIT | -26.28M | -28.45M | -29.4M | -35.43M | -42.91M | -38.27M | -38.24M | -43.5M | -46M | -37.44M | -14.63M | -32.87M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.77M | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.77M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.2M | 1.42M | 1.85M | -6.52M | 2.92M | 3.38M | 3.55M | 5.8M | 4.77M | 3.13M | 4.63M | 3.35M |
| Pretax Income | -25.09M | -27.04M | -27.55M | -54.1M | -39.99M | -35.5M | -34.68M | -37.7M | -41.23M | -34.31M | -10M | -29.52M |
| Pretax Margin % | -1046.52% | -686.07% | -1253.32% | -2028.42% | -1699.58% | -1709.15% | -1713.64% | -1088.25% | -1697.57% | -964.36% | -42.27% | -786.13% |
| Income Tax | 0 | -550K | 0 | 0 | 0 | -9K | 0 | 0 | 0 | 193K | 0 | 0 |
| Effective Tax Rate % | 0% | 2.03% | 0% | 0% | 0% | 0.03% | 0% | 0% | 0% | -0.56% | 0% | 0% |
| Net Income | -25.09M | -26.49M | -27.55M | -54.1M | -39.99M | -35.49M | -34.68M | -37.7M | -41.23M | -34.51M | -10M | -29.52M |
| Net Margin % | -1046.52% | -672.11% | -1253.32% | -2028.42% | -1699.58% | -1708.71% | -1713.64% | -1088.25% | -1697.57% | -969.79% | -42.27% | -786.13% |
| Net Income Growth % | 37.27% | 25.36% | 20.57% | -43.51% | 3.01% | -2.85% | -246.77% | -27.7% | -47.03% | -27.85% | 62.46% | -10.57% |
| Net Income (Continuing) | -25.09M | -26.49M | -27.55M | -54.1M | -39.99M | -35.49M | -34.68M | -37.7M | -41.23M | -34.51M | -10M | -29.52M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.26 | -0.28 | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 | -0.42 | -0.46 | -0.39 | -0.12 | -0.48 |
| EPS Growth % | 39.53% | 28.21% | 21.05% | -38.1% | 6.52% | 0% | -216.67% | 12.5% | 0% | 11.36% | 72.73% | -9.09% |
| EPS (Basic) | -0.26 | -0.28 | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 | -0.42 | -0.46 | -0.39 | -0.12 | -0.48 |
| Diluted Shares Outstanding | 95.86M | 94.54M | 93.29M | 93.03M | 92.68M | 90.32M | 90.46M | 90.34M | 89.3M | 88.43M | 83.78M | 61.42M |
| Basic Shares Outstanding | 95.86M | 94.54M | 93.29M | 93.03M | 92.68M | 90.32M | 90.46M | 90.34M | 89.3M | 88.43M | 83.78M | 61.42M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |